Innomotics India launches CSR program to support aspiring children
The core of the education program is the creation of the Innomotics INGenius Scholarship Program. This scholarship program serves as a gateway for exceptional students to embark on a journey of knowledge and skill development in the fields of engineering and technology. The INGenius program covers the tuition, accommodation, and essential academic expenses like books, internet as well as stationery items of selected students based on their academic achievements in the 10th and 12th standards, their aspirations and social backgrounds.
With 12 children selected for this fiscal year, the scholarship program also includes internships, soft skills training and equipping students with the necessary tools to thrive in their future careers. As part of its education initiative, Innomotics also provides support to government-funded schools, focusing on infrastructure development and vocational training.
The social pillar has partnered with two non-profit organisations – Sangopita – A Shelter for Care and Desire Society – Caring for Special Children. Sangopita supports children who are physically, mentally and sensory impaired and many of them are autistic. The children need a lifetime of care. Desire Society supports children with an objective of health development and the well-being of children living with HIV/AIDS (CLHAs). Over 120 children are part of the NGO's programs. Apart from financial aid, Innomotics India's CSR initiative supports these children by career counselling, preparing for exams, teaching and hosting special events. One such special event was the visit to the Nehru Science Planetarium.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
14 minutes ago
- The Hindu
Three held in ₹44 lakh cyber fraud case
Three persons were arrested by the cyber crime wing of the Hyderabad police for defrauding a city-based person of over ₹44 lakh by posing as trading advisors from a fictitious firm named 'Aveshta Study Group-W'. The accused were identified as Milind Manohar Narkar, 34, a private employee from Santacruz, Mumbai; Ranak Jagadish Patel, 31, a businessman from Bhiwandi, Thane; and Salik Imtiyaz Ahmed Siddiqui, 25, a private employee from Mumbra, Thane. All three were working in tandem with a cyber fraudster operating out of Dubai. According to investigators, the trio contacted the victim in June 2025 on phone, claiming to be professional trading advisors offering high return investment opportunities. Lured by the promise of substantial profits, the victim was persuaded to transfer funds into several bank accounts controlled by the accused. When the victim later attempted to withdraw the 'profits', he was asked to first pay a 20% 'service charge' on the returns. Believing the promise that both the profits and the original investment would be returned following this payment, the victim complied. In total, he was cheated of ₹44,04,753. During the investigation, it emerged that Milind Narkar was actively assisting the Dubai-based kingpin by converting fraudulently acquired funds into cryptocurrency. He also played a key role in sourcing and operating mule accounts, and was found to be accommodating account holders at various hotels in Mumbai. His network extended across seven other States in India where he allegedly facilitated the conversion of illicit gains into digital currency. The Hyderabad police seized three mobile phones from the accused. All three are believed to be working on commission for the overseas fraudster, by providing access to and managing local bank accounts used in the scam. Following the case, the Hyderabad police issued a public advisory warning citizens to be wary of suspicious investment schemes promising unusually high returns. Authorities have noted that scammers often pose as representatives of well-known firms and use forged documents, including fake SEBI certifications, to build credibility. Such fraudsters commonly advertise via platforms like Telegram, WhatsApp, Instagram and Facebook, and often share fake profit screenshots to gain victims' trust. Citizens have been urged to verify investment schemes thoroughly before parting with their money and to avoid making hasty financial decisions based on promises of quick returns. Victims of cyber fraud are advised to immediately dial 1930 or visit: for assistance.
&w=3840&q=100)
Business Standard
14 minutes ago
- Business Standard
Lenskart files IPO papers to raise Rs 2,150 crore, eyes tech and growth
Eyewear retailer Lenskart Solutions Ltd has filed preliminary documents for an initial public offering (IPO) that could raise up to ₹2,150 crore, as the company seeks to capitalise on rising demand for affordable prescription glasses and contact lenses. The offering comprises ₹2,150 crore in new shares and the sale of up to 132.3 million existing shares by current investors and company founders, according to the draft red herring prospectus (DRHP) filed with the Securities and Exchange Board of India (Sebi). Among the selling shareholders are co-founders Peyush Bansal, Neha Bansal, Amit Chaudhary and Sumeet Kapahi, along with investors including SoftBank's SVF II Lightbulb (Cayman) Ltd, Schroders Capital Private Equity Asia Mauritius Ltd, PI Opportunities Fund – II, Macritchie Investments Pte Ltd, Kedaara Capital Fund II LLP, and Alpha Wave Ventures LP. The company may also conduct a private placement of up to ₹430 crore before filing the final prospectus, which would reduce the size of the fresh issue. Sources said the firm is aiming for an IPO valuation of about $10 billion. According to the DRHP, Lenskart plans to use ₹272.6 crore from the net proceeds to open new CoCo (company-owned, company-operated) stores in India, ₹591.4 crore for lease, rent and licence payments, ₹213.4 crore for technology and cloud infrastructure, and ₹320 crore for brand marketing and promotion. Remaining funds will be used for inorganic acquisitions and general corporate purposes. Kotak Mahindra Capital Company Ltd, Morgan Stanley India Company Pvt Ltd, Avendus Capital Pvt Ltd, Citigroup Global Markets India Pvt Ltd, Axis Capital Ltd, and Intensive Fiscal Services Pvt Ltd are the book running lead managers to the issue. Founded in 2008, Lenskart launched its online platform in 2010 and opened its first retail store in New Delhi in 2013. The company aims to improve access to quality, affordable eyewear through a tech-enabled supply and distribution network. Globally and in India, Gurugram-based Lenskart competes with Titan Eyeplus, Specsmakers, Vision Express, Warby Parker and Italian eyewear conglomerate Luxottica Group. Lenskart currently operates India's largest eyewear retail network with a presence in metropolitan and smaller cities, as well as in Southeast Asia and the Middle East. It runs manufacturing units in Bhiwadi and Gurugram, supported by regional hubs in Singapore and the UAE. It targets a wide customer base with both premium and affordable brand offerings. Nearly 45 per cent of its India revenue comes from customers who engaged digitally within 90 days prior to purchase. India remains Lenskart's largest market in Asia. In FY25, the company recorded over 100 million app downloads and 105 million website visitors globally. It operates 2,723 stores—2,067 in India and 656 overseas. In FY25, Lenskart reported revenue from operations of ₹6,652.5 crore, up 22.5 per cent from ₹5,427.7 crore in FY24. The company reported a net profit of ₹297.34 crore, compared to a net loss of ₹10.15 crore in FY24. EBITDA, excluding other income, stood at ₹971 crore, up 44.5 per cent from ₹672 crore in the previous fiscal. Risk Factors However, the DRHP outlines several risks that could impact the company's operations, financials and growth outlook. Lenskart has incurred losses in the past and may continue to do so. Its geographic concentration is another concern, as a significant portion of revenue is derived from India. The company's brand strategy is heavily reliant on in-house labels, and its international ambitions carry regulatory and operational risks. The DRHP also flags potential funding needs, stating that Lenskart may require additional capital in future. Leadership continuity is another area of concern. The company is dependent on its promoters and senior management. The DRHP states that future success hinges on the continued involvement of Peyush Bansal and other key executives. Additionally, it notes that Sumeet Kapahi, one of the promoters and Global Head of Sourcing, has been unable to locate copies of his (Hons.) degree and marksheets from the University of Delhi. Operationally, Lenskart's private-label model exposes it to inventory and quality-related risks. Its franchise and partner store network introduces third-party vulnerabilities. On the technology front, Lenskart's geo-analytics tools help forecast revenue potential and payback periods. A 500-member technology team builds and maintains its core digital infrastructure—including websites, mobile apps, warehouse systems and AI-powered supply chain tools. The DRHP cites an estimated 1.3 billion people across India, Japan, Southeast Asia and the Middle East—representing 32 per cent of the global population—with refractive errors in FY25. In India, this share increased from 43 per cent (590 million) in FY20 to 53 per cent (777 million) in FY25, and is projected to reach 62 per cent (943 million) by FY30.
&w=3840&q=100)
Business Standard
14 minutes ago
- Business Standard
Street bullish on Torrent Pharma's prospects post in-line Q1 FY26
Analysts are optimistic on Torrent Pharma's growth after a solid Q1 FY26 report, with strong performance in Brazil and US generics despite currency volatility and German challenges Devangshu Datta Mumbai Listen to This Article Torrent Pharmaceuticals (Torrent) reported revenue and EBITDA that met consensus for the April-June quarter (Q1) of FY26. However, earnings were lower due to reduced other income. Torrent saw robust growth in Brazil in FY25, and the momentum continued into Q1FY26. However, currency volatility hurt earnings. There was also improved performance in the domestic formulation (DF) segment, while Germany faced headwinds. New launches are expected to drive growth in the US generics business. Sales grew 11.2 per cent year-on-year (YoY) to ₹3,180 crore. Domestic formulation revenue grew 10.8 per cent YoY to ₹1,810 crore (57 per cent of sales). US generics
